Alexion Pharmaceuticals, Inc.
NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing price July 28, 2021
Wednesday's top analyst upgrades and downgrades included Clorox, ConocoPhillips, Exxon Mobil, Ferrari, Kraft Heinz, Nvidia and Under Armour.
5 months ago
Last Updated: 5 months ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
6 months ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Alexion, DraftKings, Inovio, Netflix, Snowflake and more.
7 months ago
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
8 months ago
Last Updated: 8 months ago
Alexion Pharmaceutical shares shot up on Monday after it was announced over the weekend that the company would be acquired by AstraZeneca.
10 months ago
Monday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, American Electric Power, BJ's Wholesale Club, Clorox, HCA Healthcare, Shake Shack, USBancorp, Walt Disney and Xpeng.
10 months ago
Last Updated: 10 months ago
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
10 months ago
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
11 months ago
Friday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Apple, Callaway Golf, Facebook, Illumina, iRobot, Six Flags, Starbucks, Twitter and Yandex.
11 months ago
Last Updated: 11 months ago
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Caterpillar, Corning, DexCom, Enphase Energy, First Solar, Invesco, 3M, Microsoft, Pfizer and Wynn Resorts.
11 months ago
Last Updated: 11 months ago
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
1 year ago
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
1 year ago
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
1 year ago
24/7 Wall St. has been reviewing many sectors for leadership heading into earnings. One area that can offer some defensive strategies is biotech and pharmaceuticals.
1 year ago
Wednesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Amazon.com, Diageo, eBay, Etsy, Home Depot, MGIC Investment, Netflix, Sirius XM and Vir Biotechnology.
1 year ago
Last Updated: 1 year ago